<bill session="115" type="s" number="2440" updated="2019-10-18T16:08:03Z">
  <state datetime="2018-02-15">REFERRED</state>
  <status>
    <introduced datetime="2018-02-15"/>
  </status>
  <introduced datetime="2018-02-15"/>
  <titles>
    <title type="official" as="introduced">A bill to combat the opioid epidemic by reforming existing laws and providing for the public's safety, and for other purposes.</title>
    <title type="short" as="introduced">CARES Act</title>
    <title type="short" as="introduced">CARES Act</title>
    <title type="short" as="introduced">Comprehensive Addiction Reform, Education, and Safety Act of 2018</title>
    <title type="short" as="introduced">Comprehensive Addiction Reform, Education, and Safety Act of 2018</title>
    <title type="display">CARES Act</title>
  </titles>
  <sponsor bioguide_id="C000127"/>
  <cosponsors>
    <cosponsor bioguide_id="H001075" joined="2018-02-15"/>
  </cosponsors>
  <actions>
    <action datetime="2018-02-15">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2018-02-15" state="REFERRED">
      <text>Read twice and referred to the Committee on the Judiciary.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSJU" name="Senate Judiciary" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Crime and law enforcement"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Business records"/>
    <term name="Civil actions and liability"/>
    <term name="Department of Justice"/>
    <term name="Drug Enforcement Administration (DEA)"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Executive agency funding and structure"/>
    <term name="Government information and archives"/>
    <term name="Marketing and advertising"/>
    <term name="Prescription drugs"/>
    <term name="Television and film"/>
  </subjects>
  <amendments/>
  <summary date="2018-02-15T05:00:00Z" status="Introduced in Senate">Comprehensive Addiction Reform, Education, and Safety Act of 2018 or the CARES Act

This bill establishes new requirements related to the marketing and distribution of controlled substances.

Among other things, the bill does the following:

 requires predissemination review of television advertisements for controlled substances, increases penalties for drug manufacturers who commit certain violations involving opioids, and requires the prior conviction records of opioid manufacturers to be made publicly available.</summary>
  <committee-reports/>
</bill>
